Outcome of Board Meeting

SANGINITA CHEMICALS LTD. (Erstwhile known as Sanginita Chemicals Pvt. Ltd.) MANUFACTURERS & SUPPLIERS OF CHEMICALS Regd. Office : 301, Shalin Complex, B/H Megh Malhar Complex, Sector-11, Gandhinagar - 382 011, Gujarat State. Factory ¢ Block No. 1133, Nr.GIDC-Chhatral Phase IV, At.; Chhatral, Ta. Kalol, Dist. Gandhinagar, Gujarat State. Phone : (0.& Fax) 079-23240270, M.: 98240 65056, 93270 23982, 98792 30034 e-mail : dbchavada@yahoo.co.in / sanginitachemicals@yahoo.com Website : www.sanginitachemicals.co.in. CIN 1 L24100GJ2005PLC047292 Date:- 13.08.2026 The Manager Listing Department National Stock Exchange of India Limited Exchange Plaza, C-1, Block-G Bandra Kurla Complex Bandra East, Mumbai - 400051 Symbol: SANGINITA Outcome of Board Meeting held on 13" August 2026. Dear Sir/Madam, Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations™). In terms of Regulation 33 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III thereto, we wish to inform you that the Board of Directors of the Company, at its meeting held today, i.e., 13® August 2026, inter alia, has considered and approved the following business(s): 1. Considered and approved the Unaudited Standalone & Consolidated Financial Results for the quarter ended on 30 June 2026; (Copy enclosed). 2. Considered and took on record the Limited Review Report on Unaudited Standalone & Consolidated Financial Results for the quarter ended on 30™ June 2026, as issued by M/s. B.K. Chavda & Co., Statutory Auditors of Company; (Copy enclosed). 3. Approval for appointment of Mr. Alok Jain (DIN: 01892711) as an Additional Non-Executive Independent Director of the Company 4. Appoint M/s Dileep Verma & Associates, Cost Accountants, as Cost auditor of the Company, and to fix their remuneration. 5. Appoint Mr. Vaibhav Kumar Valiyan, as an Internal Auditor of the Company, and to fix their remuneration thereto. SANGINITA CHEMICALS LTD. (Erstwhile known as Sanginita Chemicals Pvt. Ltd.) MANUFACTURERS & SUPPLIERS OF CHEMICALS Regd. Office : 301, Shalin Complex, B/H Megh Malhar Complex, Sector-11, Gandhinagar - 382 011, Gujarat State. Factory ¢ Block No. 1133, Nr.GIDC-Chhatral Phase IV, At.; Chhatral, Ta. Kalol, Dist. Gandhinagar, Gujarat State. Phone : (0.& Fax) 079-23240270, M.: 98240 65056, 93270 23982, 98792 30034 e-mail : dbchavada@yahoo.co.in / sanginitachemicals@yahoo.com Website : www.sanginitachemicals.co.in. CIN 1 L24100GJ2005PLC047292 The Meeting of Board of Directors commenced at 5.00 p.m. and concluded at 5:30 p.m. Kindly take the above information on record. Yours sincerely, For SANGINITA CHEMICALS LIMITED Digitally signed Gaurav by Gaurav Kumar Kumar Tripathi Tri. pathi . D1a9te2:5 42302460.0583.013 GAURAV KUMAR TRIPATHI WHOLE-TIME DIRECTOR DIN:06372272 SANGINITA CHECMIALS LIMITED (CIN: L24100GJ2005PLC047292) Registered Office: 301, 3 Floor, Shalin Complex, Sector-11, Gandhinagar -382011(Gujarat) STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED ON 30" JUNE, 2026 (Amount in Lakhs) Quarter ended on Year ended on 31-03-2026 Particulars (Audited) 30-06-2026 31-03-2026 30-06-2025 Unaudited Audited Unaudited I | Revenue from Operation 2531.12 4297.17 4591.04 17645.81 II | Other Income 7.17 0.03 37.36 38.47 it Total Income (1 + II) 2538.29 4297.20 4628.40 17684.28 IV | Expenses Cost of Materials consumed 1848.68 2246.56 2269.14 8926.33 Purchase of stock-in-trade 1549.53 2555.52 2193.98 9196.52 Changes in inventories of finished goods, 120.87 26.69 117. Stock-in-trade and work-in progress (26.69) (18.72) (117.80) Employee benefits expense 40.68 19.12 2891 97.67 Finance Costs 3.68 43.45 53.04 192.09 Depreciation and amortisation expense 46.11 54.09 54.24 219.15 Other Expenses 66.78 42.20 37.76 142.84 Total Expenses (IV) 3676.33 4931.25 4618.35 18656.80 V | Profit/(loss) before exceptional items (1138.04) 10.05 and tax (I1I- IV) (634.05) (972.52) VI | Exceptional Items - - - VII | Profit / (Loss) before tax (V-VI) (1138.04) (634.05) 10.05 (972.52) VIII | Tax expense [Less/(Add)]: R (1) Current Tax - N (2) Short/ (Excess) Provision of IT - 044 (022) earlier years written back 0.74 0.72) (3.57) (3) Deferred Tax 3.64 ( ) IX | Profit (Loss) for the period from (1141.68) 10.77 2.87) 968.7. continuing operations (VII-VIII) (632.87) (68.73) X | Profit/(loss) from discontinued - - - - operations XI | Tax expense of discontinued operations - - - - XII | Profit/(loss) from Discontinued - - - - operations (after tax) (X-XI) XIII | Profit/(loss) for the period (IX+XIT) (1141.68) (632.87) 10.77 (968.73) XIV | Other Comprehensive Income A (i) Items that will not be reclassified to - - - - profit or loss (ii) Income tax relating to items that will - - - - not be reclassified to profit or loss Gaurav | Dbigiltal ly fore signed Page 10f2 Kumar kumarTripathi Date: 2026.08.13 Tripathi 17:55:26 +05'30" B (i) Items that will be reclassified to - - - - profit or loss (ii) Income tax relating to items that will - - - - be reclassified to profit or loss XV | Total Comprehensive Income for the (1141.68) (632.87) 10.77 (968.73) period (XIII+XIV)(Comprising Profit (Loss) and Other Comprehensive Income for the period) XVI | Earnings per equity share (for continuing operation): (1) Basic & (3.56) (2.44) 0.04 3.74) (2) Diluted (3.56) (2.44) 0.04 3.74) XVII| Earnings per equity share (for discontinued operation): (1) Basic & - - - - (2) Diluted - - - - XVIII| Earnings per equity share(for discontinued & continuing operations) (1) Basic & (3.56) (2.44) 0.04 3.74) (2) Diluted (3.56) (2.44) 0.04 3.74) XIX | Paid-up equity shares capital 6034.60 2590.16 2590.16 2590.16 (Face Value Rs. 10/- each) XX | Reserves excluding Revaluation Reserves - - - - as per Balance sheet of Previous accounting year Notes: 1. The above results have been reviewed by the Audit Committee and taken on record by the Board of Directors at their meeting held on 13" Aug, 2026 and the same have been subjected to limited review by the Statutory Auditors of the Company. 2. The figures for the corresponding previous period have been restated/regrouped wherever necessary, to make them comparable. In line with Ind AS - 108 - "Operating Segments", the operations of the company fall under chemical business which is considered to be the only reportable business segment. FOR SANGINITA CHEMICALS LIMITED Gauray Diotalysigned by Gaurav Kumar e, Tripathi 175560530 Gaurav Kumar Tripathi Whole Time Director (DIN: 06372272) Place: Noida Date: 13" August, 2026 Page2 of 2 Notes to Accounts 1. Change in Control, Acquisition of Subsidiary and Change in Management During the quarter ended 30 June 2026, pursuant to the Share Swap and Share Purchase Agreement (“SSSPA”) dated 20 March 2026 and related transactions, BNG Investment LLC and Mr. Anubhav Agarwal became the new promoters/acquirers of the Company, resulting in a change in control and management. Necessary regulatory disclosures have been made with the Stock Exchange. Pursuant to the share-swap arrangement, the Company acquired 100% equity share capital of Agastya Green Energy Limited (“AGEL”) comprising 94,99,994 equity shares and 6 remaining shares with nominee shareholders, as consideration other than cash, issued 1,52,87,356 equity shares of the Company to BNG Investment LLC. The transaction was completed on 10 June 2026, and consequently AGEL became a wholly owned subsidiary of the Company from that date. Accordingly, the financial results of AGEL and its relevant subsidiaries/associates/investees have been considered in the Consolidated Financial Results from the respective dates of obtaining control/significant influence, in accordance with applicable Indian Accounting Standards. 2. Change in Promoter Group and Management Consequent to the aforesaid transaction, there was a change in the promoter/promoter group, Board and key managerial personnel of the Company. The [Showing first 8,000 characters — download PDF for full document]